MedPath

Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis

Recruiting
Conditions
Anorexia Nervosa
Registration Number
NCT06262165
Lead Sponsor
Nantes University Hospital
Brief Summary

The main goal of the BIocoLlection in Anorexia Nervosa-liver damage evaluation BILAN study the blood biomarkers associated with liver cytolysis.

Detailed Description

Study of the association between blood biomarkers and the presence of hepatic cytolysis, defined by AST and/or ALT above normal.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification of new blood biomarkers and hepatic cytolysisTwo years

Identify changes in concentration of new blood biomarkers in patients suffering from hepatic cytolysis, defined by aspartate transaminases (AST) and/or alanine transaminases (ALT) above normal values, compared to those with normal enzyme levels.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nantes University Hospital

🇫🇷

Nantes, Loire-Atlantique, France

© Copyright 2025. All Rights Reserved by MedPath